Research Paper Volume 12, Issue 20 pp 20835—20861
SMARCD3 is a potential prognostic marker and therapeutic target in CAFs
Figure 6. (A) IHC staining indicated that SMARCD3 was mainly expressed colon cancer associated fibroblasts. (B) SMARCD3 expression was most associated with fibroblasts by ssGSEA analysis.